University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Medicine (St Vincent's)
  • Medicine (St Vincent's) - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Medicine (St Vincent's)
  • Medicine (St Vincent's) - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    The epidemiological and pathogenic association of rheumatoid arthritis with atherosclerotic cardiovascular disease.

    Thumbnail
    Download
    Published version (290.2Kb)

    Citations
    Altmetric
    Author
    Nikpour, M; Brady, SRE; Liew, D
    Date
    2011
    Source Title
    Journal of Clinical Rheumatology & Musculoskeletal Medicine
    Publisher
    [Stanmore] : San Lucas Medical
    University of Melbourne Author/s
    Nikpour, Mandana
    Affiliation
    Medicine (St Vincent's)
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Nikpour, M., Brady, S. R. E. & Liew, D. (2011). The epidemiological and pathogenic association of rheumatoid arthritis with atherosclerotic cardiovascular disease.. Journal of Clinical Rheumatology & Musculoskeletal Medicine, 2 (1), pp.34-44
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/221713
    Abstract
    Rheumatoid arthritis (RA) is associated with an approximately twofold increased risk of atherosclerotic cardiovascular disease (CVD) including myocardial infarction and stroke. The increased risk of CVD in RA is due to an interplay between traditional risk factors such as hyperlipidemia, hypertension, and smoking and disease-related variables such as the presence of rheumatoid factor and anticyclic citrullinated peptide antibodies, high erythrocyte sedimentation rate, and joint swelling. Systemic inflammation and immune mechanisms form a pathogenic link between synovitis and atherosclerosis in RA. Indeed, high levels of C-reactive protein, an inflammatory marker, predict cardiovascular mortality in RA. Furthermore, the risk of CVD is greatly diminished among patients who respond to disease modifying antirheumatic drugs and biological therapies such as tumor necrosis factor (TNF) alpha antagonists. Through adverse effects on lipid profile and blood glucose level, long-term use of high-dose glucocorticoids in RA also increases cardiovascular risk. However, through control of active disease, glucocorticoids may also indirectly attenuate cardiovascular risk. Through their lipid-lowering and immunomodulatory effects, statins may have a dual benefit in the treatment of patients with RA. However, data on cardiovascular risk reduction in RA through management of traditional risk factors remain scant. Current research efforts are directed toward elucidating the risk factors for CVD in RA and developing strategies to minimize this risk.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [45689]
    • Medicine (St Vincent's) - Research Publications [242]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors